All lobbying filings
WAXMAN STRATEGIES
WAXMAN STRATEGIES filed a Q3 report for 340B HEALTH on October 21, 2026, reporting $39,000 in lobbying income.
Lobbying for 340B HEALTH · advocacy and membership organization
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 21, 2026
Income
$39,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
2
-
HENRY WAXMAN Former member of CongressPreviously held: US House of Representatives 1975 to 2015
-
JEREMY SHARP New on this filingPreviously held: LA,Rep Capps 2001-05 PSM, Sen HELP Comm 2007-10 LD, Sen Dodd 2010 DAS for Leg, HHS, 2011-13 Counselor, HHS, 2013-14 Dep Commissioner for Policy, FDA 2015-17
Government bodies contacted
2
Lobbying activity
2
Issues affecting the 340B drug pricing program; appropriations for 340B program
Issues affecting the 340B drug pricing program; Appropriations for 340B program.